Days to first week
Reticulocyte count and early hematologic markers can begin improving quickly after starting an adequate dose.
Protocol / Research Dosing Guide
Vitamin B12 Dosage Guide: Injectable and Oral Deficiency Protocols
An evidence-organized Vitamin B12 reference covering the established injectable and high-dose oral deficiency protocols, with a clear note that B12 is a vitamin, not a peptide.
Last reviewed September 16, 202614 minute readResearch information only
Level 6 — FDA approved (injectable cyanocobalamin/hydroxocobalamin) for B12 deficiencyExtensive human trial and clinical-practice evidenceNot a peptide; an essential water-soluble vitamin
Vitamin B12 Quick Start
Vitamin B12 is not a peptide; it is an essential water-soluble vitamin (cobalamin) that the body needs for red blood cell formation and nerve function. Its evidence base is unusually large and settled compared with most compounds on this site: decades of clinical trials and practice guidelines define a standard 1,000 mcg dose used by injection or high-dose oral tablet, and a clear loading-then-maintenance structure. It has an FDA-approved injectable role for correcting deficiency and pernicious anemia, and one of the cleanest safety records in clinical nutrition, because it is water-soluble and excess is excreted in urine.
Why researchers care
Correction of vitamin B12 deficiency, pernicious anemia, and malabsorption-related deficiency
Class
Cobalamin, an essential water-soluble B-vitamin; not a peptide. Common forms are cyanocobalamin, hydroxocobalamin, and methylcobalamin
Route reported
Intramuscular or subcutaneous injection; high-dose oral or sublingual tablet
Cycle length
A loading phase to refill body stores, followed by long-term maintenance dosing; duration depends on the cause of the deficiency
Regulatory status
FDA approved as injectable cyanocobalamin and hydroxocobalamin for vitamin B12 deficiency and pernicious anemia; also widely available as an unregulated over-the-counter oral supplement
Loading supplier information
Vitamin B12 Dosing Protocol and Schedule
The supplied source reports a standard dose of 1,000 mcg (1 mg) per injection, with a loading phase of 1,000 mcg daily or on alternate days for 1-2 weeks (or roughly six doses over 1-2 weeks with neurologic involvement), followed by maintenance of 1,000 mcg intramuscularly every month for cyanocobalamin or every 1-3 months for hydroxocobalamin, which is retained longer in the body. It also reports a high-dose oral alternative of 1,000-2,000 mcg daily and states that research-grade B12 is most commonly sold as a pre-dissolved liquid rather than a lyophilized powder, so reconstitution math is usually unnecessary.
| Phase or study | Amount | Frequency / evidence |
|---|---|---|
| Loading phase (general deficiency) | 1,000 mcg daily or on alternate days for 1-2 weeks | Clinical literature |
| Loading phase (neurologic involvement) | About 6 doses of 1,000 mcg over 1-2 weeks | Clinical literature |
| Maintenance (cyanocobalamin) | 1,000 mcg intramuscularly every month | Clinical literature |
| Maintenance (hydroxocobalamin) | 1,000 mcg intramuscularly every 1-3 months | Clinical literature; retained longer than cyanocobalamin |
| High-dose oral alternative | 1,000-2,000 mcg daily | Randomized trials and systematic reviews |
| Upper limit | None established | Water-soluble; excess is excreted |
Unlike most compounds covered on this site, this schedule reflects a mature, widely replicated clinical evidence base rather than community reports. A clinician still matches the exact schedule to the underlying cause of deficiency (dietary insufficiency, malabsorption, or pernicious anemia), since these behave differently over time and injections are reserved mainly for severe deficiency, neurologic involvement, or when daily oral adherence is impractical.
Vitamin B12 Supplies Needed
Neutral research-material planning only. This does not establish an appropriate amount or route.
Research planning item
Exact labeled research or pharmacy vial (commonly 10 mg pre-dissolved liquid at about 1 mg/mL)
Research planning item
U-100 insulin syringes, or a 1-3 mL syringe depending on injection volume
Research planning item
Alcohol prep swabs
Research planning item
Sharps container
Research planning item
Refrigeration or room-temperature storage per the product label
Research planning item
High-dose oral tablets, if using the oral alternative instead of injection
Vitamin B12 Reconstitution Calculator
Vial-format concentration math
Concentration
1 mg/mL
Draw volume
1 mL
U-100 units
100
Mathematical draws
10
Arithmetic only. The entered amount is not a recommendation and does not establish suitability.
Best Time to Take Vitamin B12: Morning or Night?
Morning or evening?
Not established as clinically significant; convenience generally guides timing.
Daily, alternate-day, monthly?
Loading is daily or alternate-day for 1-2 weeks; maintenance shifts to monthly (cyanocobalamin) or every 1-3 months (hydroxocobalamin).
With food?
Oral B12 absorption is not meaningfully food-dependent at the studied high doses, since most of the effect relies on passive diffusion rather than intrinsic-factor-mediated uptake.
Missed dose?
No single validated rule applies to every regimen; resuming the regular schedule and consulting the prescribing clinician is the general clinical practice for a missed maintenance dose.
Vitamin B12 Route Comparison
| Format | What is reported | Evidence limit |
|---|---|---|
| Intramuscular injection | Standard 1,000 mcg cyanocobalamin or hydroxocobalamin; the classic deficiency and pernicious-anemia protocol | Well established, FDA approved |
| Subcutaneous injection | Also used, particularly with hydroxocobalamin | Well established as an alternative to intramuscular delivery |
| High-dose oral/sublingual | 1,000-2,000 mcg daily; roughly 1% crosses by passive diffusion even without intrinsic factor | Supported by multiple randomized trials and a Cochrane review showing it matches injectable normalization of serum B12 |
| Sublingual specifically | Marketed as faster-absorbing | Published comparisons have not shown a consistent absorption advantage over swallowed oral tablets |
Routes and amounts are not interchangeable unless a verified study explicitly establishes a conversion.
Vitamin B12 Half-Life and Dosing Frequency
| Measure | Finding | Evidence limit |
|---|---|---|
| Body stores | Vitamin B12 is stored in the liver in quantities that can supply the body for months to years, which is distinct from a simple plasma half-life figure | Basis for infrequent maintenance dosing |
| Plasma clearance | Excess water-soluble B12 not bound to transport proteins is excreted renally | Basis for the very wide safety margin and lack of an established upper limit |
| Frequency logic | Loading is frequent to refill depleted stores; maintenance is infrequent because those stores are then large | Established by clinical practice and trial data |
| Oral versus injectable kinetics | High-dose oral relies on passive, intrinsic-factor-independent diffusion of about 1% of the dose, which is sufficient at 1,000-2,000 mcg daily | Documented across multiple randomized trials |
Vitamin B12 Dosage Chart
| Route | Amount | Frequency | Source | Human validation |
|---|---|---|---|---|
| Intramuscular/subcutaneous | 1,000 mcg | Daily or alternate-day loading, 1-2 weeks | Clinical literature | Yes, FDA-approved injectable indication for deficiency |
| Intramuscular | 1,000 mcg | Monthly maintenance (cyanocobalamin) | Clinical literature | Yes |
| Intramuscular/subcutaneous | 1,000 mcg | Every 1-3 months maintenance (hydroxocobalamin) | Clinical literature | Yes |
| Oral/sublingual | 1,000-2,000 mcg | Daily | Randomized trials, systematic review, Cochrane review | Available over the counter; matches injectable normalization in trials |
Published study values describe those studies. Community-reported values are not validated dosing recommendations.
Vitamin B12 Reconstitution Guide
Concentration: 1 mg/mL
| Entered amount | Volume | U-100 units |
|---|---|---|
| 1 mg | 1 mL | 100 units |
| 2 mg | 2 mL | 200 units |
| 3 mg | 3 mL | 300 units |
- 1.Confirm the form: research-grade B12 is most commonly sold as a pre-dissolved liquid, commonly a 10 mg vial at about 1 mg/mL, so reconstitution is usually unnecessary.
- 2.If a vial does ship as lyophilized powder, confirm the exact labeled quantity before adding any diluent.
- 3.Reconstitute only with the diluent specified on that product's label, commonly bacteriostatic water, to a known concentration.
- 4.Clean the vial stopper with an alcohol swab before each draw.
- 5.Inspect the solution; it is normally a clear, dark red or pink liquid due to cobalamin's natural color.
- 6.At a typical 1 mg/mL concentration, a standard 1,000 mcg dose is a 1.0 mL draw.
- 7.Label any reconstituted vial with the concentration and preparation date.
- 8.Store per the product label; refrigeration is commonly used, though light protection matters more than temperature for this compound.
Reconstitution does not establish identity, purity, sterility, stability, or an appropriate amount.
How Vitamin B12 Works
Vitamin, not a peptide
Vitamin B12 (cobalamin) is a cobalt-containing vitamin structure, unrelated to the amino-acid-chain peptides covered elsewhere on this site.
Vitamin B12 Human Trials and FDA Status
Current status · verified September 16, 2026
FDA approved as injectable cyanocobalamin and hydroxocobalamin for vitamin B12 deficiency and pernicious anemia; also widely available as an unregulated over-the-counter oral supplement
- Carmel's clinical review (PMID 18606874) describes the standard loading-then-maintenance injectable structure used to correct B12 deficiency and pernicious anemia.
- Kuzminski et al.'s randomized trial (PMID 9694707) found that 2,000 mcg daily oral cyanocobalamin matched or exceeded monthly 1,000 mcg injections at normalizing serum B12.
- Butler et al.'s systematic review (PMID 16585128) reached the same conclusion across multiple trials comparing oral and injectable B12.
- The Cochrane review by Wang et al. (PMID 29543316) also concluded that oral and injectable B12 have comparable effects on normalizing B12 status.
Who Should Avoid Vitamin B12?
This is an evidence-gap and precaution list, not an approved prescribing label.
Undiagnosed anemia without B12 testing
Supplementing before diagnosis can mask other underlying causes of anemia
Known hypersensitivity to cobalt or cyanocobalamin specifically
Cyanocobalamin contains a cyanide moiety in trace amount and is generally avoided in favor of hydroxocobalamin in some sensitivities, per clinical practice
Leber's hereditary optic neuropathy
Cyanocobalamin specifically is generally avoided in this condition per clinical guidance; hydroxocobalamin or methylcobalamin are typically used instead
Relying on B12 to treat unrelated fatigue without a documented deficiency
Evidence supports correcting an actual deficiency, not general energy enhancement in replete individuals
Assuming injectable is always required
High-dose oral matches injectable outcomes for most people per randomized trial and Cochrane-review evidence
No upper-limit precaution is established
None is needed for typical use given its water-soluble, self-limiting excretion, but very large or unusual doses should still be discussed with a clinician if new symptoms arise
Vitamin B12 Side Effects, Risks and Safety
Injection-site discomfortReported
Important limitation: Mild, generic to intramuscular or subcutaneous injection.
Mild diarrhea or itchingReported infrequently
Important limitation: Low incidence in clinical use.
Allergic reactionRare
Important limitation: More often associated with preservatives or cobalt sensitivity than cobalamin itself.
Hypokalemia or thrombocytosis during initial correctionReported in some severe deficiency cases
Important limitation: Related to rapid red-blood-cell production during treatment initiation; a known monitoring point in severe cases.
Overdose toxicityNot established as a clinical concern
Important limitation: Water-soluble; no established upper intake limit.
Drug interactionsLimited but documented, e.g., with metformin and certain acid-reducing medicines reducing absorption over time
Important limitation: Relevant mainly to oral absorption of the vitamin itself.
Vitamin B12 Timeline and Monitoring
1-2 weeks
Completion of the loading phase for correcting depleted stores.
Weeks to months
Neurologic symptoms, when present, may improve more slowly than blood counts and are not always fully reversible if deficiency was longstanding.
Ongoing
Maintenance dosing (monthly injection or daily high-dose oral) continues indefinitely for causes such as pernicious anemia or permanent malabsorption.
Vitamin B12 Benefits and Results: What the Evidence Shows
| Claim | Evidence level | What research shows | Important limitation |
|---|---|---|---|
| Correcting vitamin B12 deficiency | Extensive human trials | Decades of clinical trial and practice evidence | FDA-approved injectable indication; also supported for high-dose oral |
| Pernicious anemia management | Extensive human trials and clinical practice | Long-standing standard of care | FDA-approved injectable indication |
| General energy or cognitive enhancement in people without deficiency | Not established | Common marketing claim | No trial evidence supports benefit beyond correcting an actual deficiency |
| Prevention of deficiency in at-risk groups (e.g., strict vegans, older adults, some gastric surgery patients) | Established clinical guidance | Supported by absorption and dietary-intake literature | Preventive supplementation, not a treatment claim |
Vitamin B12 Storage and Handling
Sealed liquid vial
Store per the product label; protect from light, as cobalamin solutions are light-sensitive.
Oral tablets
Store at room temperature per the product label.
Prepared or opened multidose vial
Follow label guidance; refrigeration is commonly used for opened vials.
Appearance
A clear, dark red to pink solution is expected due to cobalamin's natural color; cloudiness or particles mean discard.
Vitamin B12 Troubleshooting
Vial arrived as a pre-dissolved liquid, not a powder
This is expected; most research-grade and pharmacy B12 products ship pre-dissolved and do not require reconstitution.
Unsure whether to use injectable or oral
High-dose oral matches injectable outcomes for most people per randomized trial evidence; injections are generally reserved for severe deficiency, neurologic involvement, or poor oral adherence.
Solution looks unusually pale or discolored
A clear, dark red to pink color is expected; anything cloudy or off-color should not be used.
Symptoms persist despite supplementation
Consider that an unaddressed underlying cause, such as ongoing malabsorption, may need separate clinical evaluation.
A scheduled maintenance dose is missed
No single validated rule applies to every regimen; resume the regular schedule and discuss timing with the prescribing clinician.
Vitamin B12 Comparisons
| Compound | Class or mechanism | Evidence | FDA status |
|---|---|---|---|
| Vitamin B12 (cobalamin) | Essential water-soluble vitamin, not a peptide | Extensive human trials and decades of clinical practice | FDA approved (injectable) for deficiency and pernicious anemia |
| Folate (B9) | Essential water-soluble vitamin | Extensive human trials | FDA approved for deficiency; often assessed alongside B12 |
| Thymosin Alpha-1 | Immune-modulating peptide | Multiple human trials; approved abroad | Not FDA approved in the US |
| NAD+ | Coenzyme precursor compound, not a classic peptide | Early human research | Not FDA approved as a standalone drug |
Vitamin B12 Frequently Asked Questions
Is Vitamin B12 a peptide?
No. It is an essential water-soluble vitamin (cobalamin), unrelated to the amino-acid-chain peptides otherwise covered on this site.
Is Vitamin B12 FDA approved?
Yes, injectable cyanocobalamin and hydroxocobalamin are FDA approved for correcting vitamin B12 deficiency and pernicious anemia. Oral B12 is also widely available as an unregulated over-the-counter supplement.
What is the standard dose?
1,000 mcg (1 mg) per dose, whether by injection or high-dose oral tablet.
What does the loading phase look like?
1,000 mcg daily or on alternate days for 1-2 weeks, or about six doses over 1-2 weeks when neurologic symptoms are present.
What is the maintenance schedule?
1,000 mcg intramuscularly every month for cyanocobalamin, or every 1-3 months for hydroxocobalamin, which is retained longer.
Does high-dose oral B12 really work as well as injections?
Multiple randomized trials and a Cochrane review found that 1,000-2,000 mcg daily oral cyanocobalamin normalizes serum B12 comparably to monthly injections for most people.
Is sublingual better absorbed than swallowed tablets?
Published comparisons have not shown a consistent advantage of sublingual over standard oral tablets.
Is there an upper limit or overdose risk?
None is established; it is water-soluble and excess is excreted in urine.
Who should use injections instead of oral?
People with severe deficiency, neurologic involvement, or situations where daily oral adherence is impractical, per clinical practice.
Does research-grade B12 need reconstitution?
Usually not; it is most commonly sold as a pre-dissolved liquid rather than a lyophilized powder.
Can it treat fatigue in someone without a documented deficiency?
No trial evidence supports a benefit beyond correcting an actual, tested deficiency.
Sources and Research
Coverage source
1. Vitamin B12 dosage protocol coverage source
Standard deficiency-correction schedule, loading-versus-maintenance structure, and form comparisons; not primary evidence.
Open direct sourceHuman research
2. Carmel R., How I treat cobalamin (vitamin B12) deficiency
Clinical review describing the standard injectable loading-then-maintenance treatment structure.
Open direct sourceHuman research
3. Kuzminski et al., Effective treatment of cobalamin deficiency with oral cobalamin
Randomized trial comparing high-dose oral cyanocobalamin to monthly intramuscular injection.
Open direct sourceHuman research
4. Butler et al., Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review
Systematic review concluding oral and injectable B12 can achieve comparable biochemical outcomes.
Open direct sourceHuman research
5. Wang et al., Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency (Cochrane review)
Cochrane systematic review reaching the same conclusion across multiple trials.
Open direct sourceMissing information flagged for review
- A single universal missed-maintenance-dose rule across all deficiency causes: Not established
- Long-term outcome data for full neurologic symptom reversal when deficiency was longstanding before treatment: Not established
- A formal established upper intake limit, though none is currently considered necessary given its safety profile: Not established
- Head-to-head trial data among all three injectable forms (cyanocobalamin, hydroxocobalamin, methylcobalamin) for every population: Not established